Perspective Therapeutics (CATX) Non-Current Assets (2011 - 2026)

Perspective Therapeutics has disclosed Non-Current Assets across 16 years of filings, most recently posting $150.5 million for Q2 2026.

• In Q2 2026, Non-Current Assets rose 31.14% year-over-year to $150.5 million; the TTM figure through Jun 2026 stood at $520.8 million (up 13.4% YoY), while the FY2025 annual figure was $118.6 million, up 7.86% from the prior year.
• Non-Current Assets came in at $150.5 million for Q2 2026 at Perspective Therapeutics, up from $135.4 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $150.5 million in Q2 2026 to a low of $3.4 million in Q1 2022.
• Average Non-Current Assets over 5 years is $84.8 million, with a median of $90.9 million recorded in 2024.
• Year-over-year, Non-Current Assets surged 2504.44% in 2023 and fell 3.85% in 2025.
• Over 5 years, Non-Current Assets stood at $4.9 million in 2022, then jumped by 1562.31% to $81.1 million in 2023, then jumped by 35.64% to $109.9 million in 2024, then increased by 7.86% to $118.6 million in 2025, then rose by 26.92% to $150.5 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $150.5 million in Q2 2026, $135.4 million in Q1 2026, and $118.6 million in Q4 2025.